赛特克生物科技
CTKB
5.25
-0.16
-2.96%
赛特克生物科技
US · CTKB
#3522 按市值排名
上市于 2021
5.25
-0.16
-2.96%
实时 - 追踪5344个代码 - 心跳于570秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了0.3个百分点。
机构持股
- 机构持股比例
- 63.43% -0.34pp
- 机构数量
- 184 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund37.80%
Hedge Fund16.76%
Individual/Insider8.48%
VC/PE Fund5.12%
Private Company2.31%
Public Company1.06%
Insurance Company0.20%
Government Pension Fund0.15%
Other28.10%
主要股东 截至 2026-06-30
BlackRock
7.37% · 9.58M 股
Millennium Management LLC
7.18% · 9.34M 股
Boston Partners Global Investors, Inc.
5.87% · 7.64M 股
Hillhouse Capital Management, Ltd.
5.12% · 6.66M 股
Topline Capital Management, LLC
4.83% · 6.28M 股
Vanguard Capital Management, LLC
4.37% · 5.68M 股
Wenbin Jiang
4.28% · 5.56M 股
Ming Yan
3.71% · 4.82M 股
Geode Capital Management, LLC
2.35% · 3.06M 股
Dimensional Fund Advisors
2.01% · 2.62M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 37次买入 · 13次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Wenbin Jiang | Chairperson & CEO | 4.28% |
| Ming Yan | CTO & Director | 3.71% |
| Valerie Barnett | General Counsel | 0.12% |
| William McCombe | Chief Financial Officer | 0.10% |
| Jack Ball | Lead Independent Director | 0.07% |
| Michael Holder | Independent Director | 0.05% |
| Vera Imper | Independent Director | 0.05% |
| Deborah Neff | Independent Director | 0.05% |
| Philippe Busque | Senior Vice President of Global Sales & Services | 0.03% |
| Richard Chin | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-01 | Philippe Busque | Senior Vice President of Global Sales & Services | Intent to Sell (Form 144) | -31,666 | $4.63 |
| 2026-08-17 | Glenn Muir | Independent Director | Derivative Exercise and Retained | +3,086 | -- |
| 2026-08-17 | Richard Chin | Independent Director | Derivative Exercise and Retained | +6,107 | -- |
| 2026-08-17 | Michael Holder | Independent Director | Derivative Exercise and Retained | +2,181 | -- |
| 2026-08-17 | William McCombe | Chief Financial Officer | Derivative Exercise and Sale | -11,904 | $4.67 |
| 2026-08-17 | William McCombe | Chief Financial Officer | Derivative Exercise and Retained | +23,516 | -- |
| 2026-08-17 | Wenbin Jiang | Chairperson & CEO | Derivative Exercise and Sale | -36,269 | $4.67 |
| 2026-08-17 | Wenbin Jiang | Chairperson & CEO | Derivative Exercise and Retained | +83,826 | -- |
| 2026-08-17 | Ming Yan | CTO & Director | Derivative Exercise and Sale | -8,088 | $4.67 |
| 2026-08-17 | Ming Yan | CTO & Director | Derivative Exercise and Retained | +25,182 | -- |
| 2026-08-09 | Ilan Feuchtwang | -- | Other Derivative Acquisition | +127,118 | $4.66 |
| 2026-08-09 | Ilan Feuchtwang | -- | Other Derivative Acquisition | +241,416 | -- |
| 2026-06-11 | Ming Yan | CTO & Director | Other Disposition | -135,892 | -- |
| 2026-06-09 | Deborah Neff | Independent Director | Other Derivative Acquisition | +18,261 | $4.05 |
| 2026-06-09 | Deborah Neff | Independent Director | Other Derivative Acquisition | +33,333 | -- |
| 2026-06-09 | Deborah Neff | Independent Director | Derivative Exercise and Retained | +43,973 | -- |
| 2026-06-09 | Glenn Muir | Independent Director | Other Derivative Acquisition | +29,835 | $4.05 |
| 2026-06-09 | Glenn Muir | Independent Director | Other Derivative Acquisition | +55,555 | -- |
| 2026-06-09 | Jack Ball | Lead Independent Director | Derivative Exercise and Retained | +43,973 | -- |
| 2026-06-09 | Richard Chin | Independent Director | Other Derivative Acquisition | +18,261 | $4.05 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
赛特克生物科技 讨论区 0 条评论